Decoy Therapeutics Inc.(DCOY)

Biotechnology · Houston, TX

$1.57-0.10 (-5.99%)

Delayed quote: Oct 6, 2026, 10:53 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T14:56:33.795Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:56:33.795Z.

Quote observation: 2026-10-06T14:53:50.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -14,819,957
Quote market capitalization: 835,190
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 8,289,108

FMP input reference: 4d5e19f74cb926d0196b5f3ffb65db8ff8affa0edec331fa5277d4ca2ec73e8d

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

DCOY EBITDA Yield Metrics

EBITDA YIELD

N/A

DCOY Competitors' EBITDA Yield

DCOY

Decoy Therapeutics Inc.

Current

Market Cap

$835190.00

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BJDX

Bluejay Diagnostics, Inc.

vs DCOY

Market Cap

$820528.00

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GCTK

GlucoTrack, Inc.

vs DCOY

Market Cap

$861994.00

EBITDA Yield

N/A

TTM Avg

0.07%

3Y Avg

0.06%

5Y Avg

0.06%

BBLG

Bone Biologics Corporation

vs DCOY

Market Cap

$870069.00

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDT

CDT Equity Inc.

vs DCOY

Market Cap

$669300.00

EBITDA Yield

24.23%

TTM Avg

13.08%

3Y Avg

19.90%

5Y Avg

19.90%

ASBP

Aspire Biopharma Holdings, Inc.

vs DCOY

Market Cap

$1.04M

EBITDA Yield

N/A

TTM Avg

86.52%

3Y Avg

86.52%

5Y Avg

86.52%

CMND

Clearmind Medicine Inc.

vs DCOY

Market Cap

$1.08M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HKPD

Cellyan Biotechnology Co., Ltd

vs DCOY

Market Cap

$1.11M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs DCOY

Market Cap

$559702.00

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JUNS

Jupiter Neurosciences, Inc.

vs DCOY

Market Cap

$1.18M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Decoy Therapeutics Inc. (DCOY)	$835190.00	N/A	N/A	N/A	N/A
Bluejay Diagnostics, Inc. (BJDX)vs ›	$820528.00	N/A	N/A	N/A	N/A
GlucoTrack, Inc. (GCTK)vs ›	$861994.00	N/A	0.07%	0.06%	0.06%
Bone Biologics Corporation (BBLG)vs ›	$870069.00	N/A	N/A	N/A	N/A
CDT Equity Inc. (CDT)vs ›	$669300.00	24.23%	13.08%	19.90%	19.90%
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.04M	N/A	86.52%	86.52%	86.52%
Clearmind Medicine Inc. (CMND)vs ›	$1.08M	N/A	N/A	N/A	N/A
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.11M	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$559702.00	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.18M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

DCOY EBITDA Yield Metrics

DCOY Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics